While its primary role is blood sugar management, patients often experience weight loss as a secondary benefit
Here's how: Employer Opt-In Plans Some employers specifically add GLP-1 weight loss drug coverage to their Kaiser plan
Its a fair question, especially if youre trying to plan ahead or make the most of every dose
A new generation of these medications has transformed treatment possibilities for people who have type 2 diabetes (Ozempic, Mounjaro) or who have obesity or are overweight with a related health condition (Wegovy, Zepbound, Foundayo)
Studies show patients may regain an average of 11.6 pounds within 52 weeks after discontinuing semaglutide
In a trial of 17,604 adults with heart disease, it cut major cardiac events heart attack, stroke, cardiac death by 20% (New England Journal of Medicine, 2023)